volume 37, issue 1, P67-70 2015
DOI: 10.1590/1516-4446-2014-1378
View full text
|
Sign up to set email alerts
|
Share

Abstract: Objective: To estimate the economic consequences of the current Brazilian government policy for attention-deficit/hyperactivity disorder (ADHD) treatment and how much the country would save if treatment with immediate-release methylphenidate (MPH-IR), as suggested by the World Health Organization (WHO), was offered to patients with ADHD. Method: Based on conservative previous analyses, we assumed that 257,662 patients aged 5 to 19 years are not receiving ADHD treatment in Brazil. We estimated the direct costs…

Expand abstract